ArticleScience (New York, N.Y.)2021

Response to Comments on "Aberrant type 1 immunity drives susceptibility to mucosal fungal infections".

Timothy J Break et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.